End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
111,700 KRW | +2.85% | +3.04% | -27.09% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company shows low valuation levels, with an enterprise value at 223.96 times its sales.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-27.09% | 3.47B | B+ | ||
+8.24% | 41.74B | B- | ||
-21.64% | 21.63B | B- | ||
-13.26% | 13.49B | B- | ||
-9.15% | 10.21B | B+ | ||
-7.37% | 9.96B | A- | ||
+15.27% | 8.05B | C+ | ||
+9.81% | 6.86B | C+ | ||
-26.59% | 5.58B | C | ||
-22.83% | 3.32B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- A011170 Stock
- Ratings Lotte Chemical Corporation